You have 9 free searches left this month | for more free features.

City

Beijing (1)

Chang Chun (1)

Condition

Immune System Disorder (1)

Plaque Psoriasis (1)

Overall Status

Completed (2)

Sign in for free

Phase

phase 1 (1)

phase 3 (1)

Sponsor

Shanghai Henlius Biotech (2)

Collaborator

Intervention

adalimumab (2)

hlx03 (2)

Study Documents

Intervention Type

drug (2)

Funder Type

Industry (2)

Study Type

Interventional (2)

hlx03

Showing 1 - 2 of 2

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Plaque Psoriasis Trial in Beijing (HLX03, adalimumab)

Completed

Plaque Psoriasis

HLX03
adalimumab

Beijing, China

Peking University People's Hospital

May 4, 2022

Immune System Disorder Trial in Chang Chun (HLX03, adalimumab)

Completed

Immune System Disorder

HLX03
adalimumab

Chang Chun, Jilin, China

the 1st affiliated hospital of Jilin University

May 4, 2022